|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/143 | (2013.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/19 | (2013.01) |
| (11) | Patento numeris | 3752132 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19703995.1 |
| Europos patento paraiškos padavimo data | 2019-02-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-12-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2019/052969 |
| Data | 2019-02-07 |
| (87) | Numeris | WO 2019/158421 |
| Data | 2019-08-22 |
| (30) | Numeris | Data | Šalis |
| 18156509 | 2018-02-13 | EP | |
| 18158053 | 2018-02-22 | EP | |
| 18194237 | 2018-09-13 | EP |
| (72) |
MARTIN, Nolwenn , AT
|
| (73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITION OF BRIGATINIB |
| PHARMACEUTICAL COMPOSITION OF BRIGATINIB |